BEAM
Price
$17.06
Change
-$0.38 (-2.18%)
Updated
Jun 13 closing price
Capitalization
1.72B
58 days until earnings call
IPSC
Price
$0.58
Change
-$0.02 (-3.33%)
Updated
Jun 13 closing price
Capitalization
49.58M
54 days until earnings call
Interact to see
Advertisement

BEAM vs IPSC

Header iconBEAM vs IPSC Comparison
Open Charts BEAM vs IPSCBanner chart's image
Beam Therapeutics
Price$17.06
Change-$0.38 (-2.18%)
Volume$1.42M
Capitalization1.72B
Century Therapeutics
Price$0.58
Change-$0.02 (-3.33%)
Volume$757.92K
Capitalization49.58M
BEAM vs IPSC Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. IPSC commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and IPSC is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 15, 2025
Stock price -- (BEAM: $17.06 vs. IPSC: $0.58)
Brand notoriety: BEAM and IPSC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 72% vs. IPSC: 93%
Market capitalization -- BEAM: $1.72B vs. IPSC: $49.58M
BEAM [@Biotechnology] is valued at $1.72B. IPSC’s [@Biotechnology] market capitalization is $49.58M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.9B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileIPSC’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • IPSC’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than IPSC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 3 TA indicator(s) are bullish while IPSC’s TA Score has 6 bullish TA indicator(s).

  • BEAM’s TA Score: 3 bullish, 5 bearish.
  • IPSC’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, IPSC is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а -8.16% price change this week, while IPSC (@Biotechnology) price change was -6.64% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.63%. For the same industry, the average monthly price growth was +13.05%, and the average quarterly price growth was +4.06%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 12, 2025.

IPSC is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (-0.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.72B) has a higher market cap than IPSC($49.6M). BEAM YTD gains are higher at: -31.210 vs. IPSC (-43.030). IPSC has higher annual earnings (EBITDA): -5.99M vs. BEAM (-399.03M). BEAM has more cash in the bank: 1.22B vs. IPSC (165M). IPSC has less debt than BEAM: IPSC (52.7M) vs BEAM (158M). IPSC has higher revenues than BEAM: IPSC (115M) vs BEAM (63.6M).
BEAMIPSCBEAM / IPSC
Capitalization1.72B49.6M3,460%
EBITDA-399.03M-5.99M6,659%
Gain YTD-31.210-43.03073%
P/E RatioN/AN/A-
Revenue63.6M115M55%
Total Cash1.22B165M739%
Total Debt158M52.7M300%
TECHNICAL ANALYSIS
Technical Analysis
BEAMIPSC
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend about 1 month ago
79%
Bullish Trend 5 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AMECX26.28-0.14
-0.53%
American Funds Income Fund of Amer A
ALCEX14.15-0.12
-0.84%
Avantis U.S. Large Cap Value G
TMLCX36.44-0.44
-1.19%
SEI Tax-Managed Large Cap F (SIMT)
SCGVX31.83-0.50
-1.55%
Sands Capital Global Growth Inv
TSQIX12.71-0.21
-1.63%
AMG TimesSquare Small Cap Growth I

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
-2.18%
CRSP - BEAM
72%
Closely correlated
+0.19%
NTLA - BEAM
64%
Loosely correlated
-0.48%
RXRX - BEAM
64%
Loosely correlated
-4.84%
DNLI - BEAM
61%
Loosely correlated
-2.51%
VERV - BEAM
58%
Loosely correlated
-2.53%
More

IPSC and

Correlation & Price change

A.I.dvisor indicates that over the last year, IPSC has been loosely correlated with CRSP. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if IPSC jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPSC
1D Price
Change %
IPSC100%
-4.10%
CRSP - IPSC
57%
Loosely correlated
+0.19%
IMNM - IPSC
51%
Loosely correlated
-6.03%
CRBU - IPSC
51%
Loosely correlated
-4.31%
NTLA - IPSC
50%
Loosely correlated
-0.48%
BEAM - IPSC
50%
Loosely correlated
-2.18%
More